<DOC>
	<DOCNO>NCT00148382</DOCNO>
	<brief_summary>The purpose study investigate amount metabolites ATL-962 blood investigate effect ATL-962 amount fat excrete faeces subject obese</brief_summary>
	<brief_title>Study Blood Levels Effects ATL-962 Fat Excretion Obese Subjects</brief_title>
	<detailed_description>Obesity significant increase clinical problem . There need effective therapeutic agent help people reduce weight . ATL-962 lipase inhibitor could reduce amount fat absorb person 's diet , lead weight reduction .</detailed_description>
	<criteria>Obese , otherwisehealthy subject Body mass index 3045kg/m2 Women pregnant breast feed Any drug treatment within 2 week commencement dose study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>